123 related articles for article (PubMed ID: 23859358)
21. Development of glycyrrhetinic acid-modified stealth cationic liposomes for gene delivery.
He ZY; Zheng X; Wu XH; Song XR; He G; Wu WF; Yu S; Mao SJ; Wei YQ
Int J Pharm; 2010 Sep; 397(1-2):147-54. PubMed ID: 20667672
[TBL] [Abstract][Full Text] [Related]
22. Hepatocyte-targeting gene delivery using a lipoplex composed of galactose-modified aromatic lipid synthesized with click chemistry.
Sakashita M; Mochizuki S; Sakurai K
Bioorg Med Chem; 2014 Oct; 22(19):5212-9. PubMed ID: 25155912
[TBL] [Abstract][Full Text] [Related]
23. Cationic liposome (DC-Chol/DOPE=1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression.
Maitani Y; Igarashi S; Sato M; Hattori Y
Int J Pharm; 2007 Sep; 342(1-2):33-9. PubMed ID: 17566677
[TBL] [Abstract][Full Text] [Related]
24. In vivo gene delivery to the liver using novel galactosylated cationic liposomes.
Kawakami S; Fumoto S; Nishikawa M; Yamashita F; Hashida M
Pharm Res; 2000 Mar; 17(3):306-13. PubMed ID: 10801219
[TBL] [Abstract][Full Text] [Related]
25. Cytofectin amine head group modification and degree of liposome pegylation: factors influencing gene transfer.
Daniels A; Noor-Mahomed N; Singh M; Ariatti M
Indian J Pharm Sci; 2011 Jul; 73(4):381-6. PubMed ID: 22707820
[TBL] [Abstract][Full Text] [Related]
26. Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecyl-7-hydroxycoumarin.
Zuidam NJ; Barenholz Y
Biochim Biophys Acta; 1997 Oct; 1329(2):211-22. PubMed ID: 9371413
[TBL] [Abstract][Full Text] [Related]
27. Exploitation of De Novo helper-lipids for effective gene delivery.
Kurosaki T; Kitahara T; Teshima M; Nishida K; Nakamura J; Nakashima M; To H; Hukuchi H; Hamamoto T; Sasaki H
J Pharm Pharm Sci; 2008; 11(4):56-67. PubMed ID: 19183514
[TBL] [Abstract][Full Text] [Related]
28. Low toxicity of cationic lipid-based emulsion for gene transfer.
Choi WJ; Kim JK; Choi SH; Park JS; Ahn WS; Kim CK
Biomaterials; 2004 Dec; 25(27):5893-903. PubMed ID: 15172502
[TBL] [Abstract][Full Text] [Related]
29. Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: synthesis, characterization, and proof of concept of hepatospecific delivery.
Pathak PO; Nagarsenker MS; Barhate CR; Padhye SG; Dhawan VV; Bhattacharyya D; Viswanathan CL; Steiniger F; Fahr A
Carbohydr Res; 2015 May; 408():33-43. PubMed ID: 25841057
[TBL] [Abstract][Full Text] [Related]
30. Novel Galactosylated Poly(ethylene glycol)-Cholesterol for Liposomes as a Drug Carrier for Hepatocyte-Targeting.
Zhang H; Xiao Y; Cui S; Zhou Y; Zeng K; Yan M; Zhao C
J Nanosci Nanotechnol; 2015 Jun; 15(6):4058-69. PubMed ID: 26369013
[TBL] [Abstract][Full Text] [Related]
31. Novel ortho ester-based, pH-sensitive cationic lipid for gene delivery in vitro and in vivo.
Guo X; Gagne L; Chen H; Szoka FC
J Liposome Res; 2014 Jun; 24(2):90-8. PubMed ID: 24188532
[TBL] [Abstract][Full Text] [Related]
32. DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery.
Zhang Y; Li H; Sun J; Gao J; Liu W; Li B; Guo Y; Chen J
Int J Pharm; 2010 May; 390(2):198-207. PubMed ID: 20116418
[TBL] [Abstract][Full Text] [Related]
33. Novel cholesterol-based cationic lipids as transfecting agents of DNA for efficient gene delivery.
Ju J; Huan ML; Wan N; Qiu H; Zhou SY; Zhang BL
Int J Mol Sci; 2015 Mar; 16(3):5666-81. PubMed ID: 25768346
[TBL] [Abstract][Full Text] [Related]
34. Effect of lipid composition on the structure and theoretical phase diagrams of DC-Chol/DOPE-DNA lipoplexes.
Muñoz-Ubeda M; Rodríguez-Pulido A; Nogales A; Martín-Molina A; Aicart E; Junquera E
Biomacromolecules; 2010 Dec; 11(12):3332-40. PubMed ID: 21058732
[TBL] [Abstract][Full Text] [Related]
35. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
[TBL] [Abstract][Full Text] [Related]
36. On the gene delivery efficacies of pH-sensitive cationic lipids via endosomal protonation: a chemical biology investigation.
Singh RS; Gonçalves C; Sandrin P; Pichon C; Midoux P; Chaudhuri A
Chem Biol; 2004 May; 11(5):713-23. PubMed ID: 15157882
[TBL] [Abstract][Full Text] [Related]
37. The analysis of serum effects on structure, size and toxicity of DDAB-DOPE and DC-Chol-DOPE lipoplexes contributes to explain their different transfection efficiency.
Esposito C; Generosi J; Mossa G; Masotti A; Castellano AC
Colloids Surf B Biointerfaces; 2006 Dec; 53(2):187-92. PubMed ID: 17049213
[TBL] [Abstract][Full Text] [Related]
38. The Impact of Lipid Types and Liposomal Formulations on Osteoblast Adiposity and Mineralization.
Chang SF; Yeh CC; Chen PJ; Chang HI
Molecules; 2018 Jan; 23(1):. PubMed ID: 29301300
[TBL] [Abstract][Full Text] [Related]
39. Asialoglycoprotein receptor-targeted liposomes loaded with a norcantharimide derivative for hepatocyte-selective targeting.
Liu X; Han M; Xu J; Geng S; Zhang Y; Ye X; Gou J; Yin T; He H; Tang X
Int J Pharm; 2017 Mar; 520(1-2):98-110. PubMed ID: 28167263
[TBL] [Abstract][Full Text] [Related]
40. Targeted gene delivery to hepatoma cells using galactosylated liposome-polycation-DNA complexes (LPD).
Sun X; Hai L; Wu Y; Hu HY; Zhang ZR
J Drug Target; 2005 Feb; 13(2):121-8. PubMed ID: 15823963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
